Final results of NKTR-102, a topoisomerase I inhibitor-polymer conjugate, in patients (Pts) with pretreated metastatic breast cancer (MBC) demonstrating significant antitumor activity.
暂无分享，去创建一个
E. Perez | S. Chan | J. Hamm | A. Awada | G. Jerusalem | P. Barrett-Lee | V. Cocquyt | R. Coleman | L. Masuoka | M. Huizing | A. Hannah | C. Zhao | M. Brown | S. O'Reilly | A. Mehdi | A. Garcia | K. Sideras | D. Young | A. Leung